Roger Ulrich

Enthusiast
DISC Type : i

Chairman, Board Of Directors at Link Immunotherapeutics

Greater Seattle Area, United States

Overview

Roger Ulrich is a biotech entrepreneur and executive with over 30 years of experience in drug discovery and development. He founded Calistoga Pharmaceuticals, developing the cancer drug Zydelig®, and served as CSO at Acerta Pharma through its acquisition by AstraZeneca. He holds a PhD from West Virginia University.

Outside of his direct scientific and executive work, he shows an interest in broader public health discussions. He has shared positions from the American Society of Clinical Oncology on cancer risks associated with lifestyle choices, highlighting the importance of public awareness in disease prevention.

He founded Calistoga Pharmaceuticals and led the development of Zydelig®, which resulted in the companys acquisition by Gilead Sciences for up to $600 million.

Personality Overview

Story Driven

Non-Confrontational

Consensus Focused

They prefer to build relationships rather than staying totally transactional.  Unlike D or C types, they are convinced more by stories and testimonials. They are generally friendly, so be careful when relying on their word.

Topics They Care About

Oncology Therapeutics
He has founded and led companies like Calistoga and Acerta, focusing on developing novel drugs for treating hematologic malignancies and other cancers.
Biotech Entrepreneurship
He has a strong record of founding and guiding successful biotech companies, such as Calistoga Pharmaceuticals and Acerta Pharma, through major acquisitions by Gilead and AstraZeneca.
Biotech Investing
Serves as a Senior Advisor to Frazier Healthcare Partners and a Scientific Advisor to BioGeneration Ventures, influencing the financing and strategy of emerging pharmaceutical companies.

Media Appearances

Roger has no verified media appearances

Work History

7-2019 - 11-2023
Chairman, Board Of Directors at Link Immunotherapeutics
4-2017
Scientific Advisor at BGV (BioGeneration Ventures)
9-2016
Senior Advisor at Frazier Healthcare Partners
Member Board of Directors at Telios Pharma, Inc.
Member Board of Directors at Kartos Therapeutics, Inc.

Education

PhD from West Virginia University
Master of Science - MS from Western Michigan University

More Information

Social Presence :

Prographics :

Exp : 7 Location : Greater Seattle Area, United States Job Level : N/A Designation : Chairman, Board Of Directors at Link Immunotherapeutics
URL has been copied!

Insights For Selling To Roger

During A Call Or A Meeting

DO's

  • Invite them for a lunch or a drink/coffee
  • Maintain high, positive energy and convey confidence
  • Give them the opportunity to lead the conversation where possible

DONT's

  • Don’t ask too many questions in one go, weave them into the flow
  • Avoid overloading them with too much information
  • Don’t be excessively objective, be like a storyteller with them

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Roger is

  • Relationship and rapport are valuable for them, but so is proven product value.
  • Will you ever get a clear answer from Roger

  • They will hardly ever say a direct no.

Insights For Deal Planning

    How fast (or slow) will Roger move?

  • Even when they are constantly engaged, they do not reach decisions quickly.
  • Can Roger take some risk or not?

  • They can take some low-probability risks if needed.

You And Roger

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.